BioCatalyst

SRPT — Sarepta Therapeutics, Inc. catalysts

2 verified catalyst event(s) for Sarepta Therapeutics, Inc. (ticker SRPT). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-10-31 — A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Du · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-31
in 1mo
ESTIMATED
 READOUT
A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participan
Phase 3 · Muscular Dystrophy, Duchenne
 SRPT Sarepta Therapeutics, Inc. Eteplirsen ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-12-31
in 3mo
ESTIMATED
 READOUT
Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy
Phase 1/2 · Myotonic Dystrophy 1
 SRPT Sarepta Therapeutics, Inc. SRP-1003 IV Infusion, SRP-1003 SC Inject ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.